{"organizations": [], "uuid": "ad94549c8dbdb774e933a22eb14de693ddcc374f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pernix-announces-launch-of-authori/brief-pernix-announces-launch-of-authorized-generic-of-treximet-idUSFWN1Q61D7", "country": "US", "domain_rank": 408, "title": "BRIEF-Pernix Announces Launch Of Authorized Generic Of Treximet", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-16T23:03:00.000+02:00", "replies_count": 0, "uuid": "ad94549c8dbdb774e933a22eb14de693ddcc374f"}, "author": "", "url": "https://www.reuters.com/article/brief-pernix-announces-launch-of-authori/brief-pernix-announces-launch-of-authorized-generic-of-treximet-idUSFWN1Q61D7", "ord_in_thread": 0, "title": "BRIEF-Pernix Announces Launch Of Authorized Generic Of Treximet", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "pernix therapeutics holdings inc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 16, 2018 / 9:06 PM / in 7 minutes BRIEF-Pernix Announces Launch Of Authorized Generic Of Treximet Reuters Staff 1 Min Read Feb 16 (Reuters) - Pernix Therapeutics Holdings Inc: * PERNIX THERAPEUTICS ANNOUNCES LAUNCH OF AUTHORIZED GENERIC VERSION OF TREXIMET® BY COMPANY’S SUBSIDIARY, MACOVEN PHARMACEUTICALS * PERNIX THERAPEUTICS HOLDINGS INC - ‍DESPITE LAUNCH OF AN AUTHORIZED GENERIC, PERNIX EXPECTS A SIGNIFICANT DECREASE IN SALES OF TREXIMET IN 2018​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-16T23:03:00.000+02:00", "crawled": "2018-02-16T23:15:10.022+02:00", "highlightTitle": ""}